Inogen (NASDAQ:INGN) and VWR (VWR) Financial Survey

Inogen (NASDAQ: INGN) and VWR (NASDAQ:VWR) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk.

Valuation and Earnings

This table compares Inogen and VWR’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Inogen $202.83 million 12.38 $20.51 million $1.23 97.83
VWR $4.51 billion 0.97 $148.20 million $1.14 29.17

VWR has higher revenue and earnings than Inogen. VWR is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Inogen and VWR’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Inogen 11.36% 13.37% 11.16%
VWR 4.11% 11.79% 3.67%

Institutional and Insider Ownership

96.7% of VWR shares are owned by institutional investors. 5.3% of Inogen shares are owned by insiders. Comparatively, 35.5% of VWR shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Inogen and VWR, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inogen 0 3 2 1 2.67
VWR 0 1 1 0 2.50

Inogen currently has a consensus target price of $98.50, suggesting a potential downside of 18.14%. VWR has a consensus target price of $32.00, suggesting a potential downside of 3.76%. Given VWR’s higher probable upside, analysts plainly believe VWR is more favorable than Inogen.

Summary

Inogen beats VWR on 9 of the 14 factors compared between the two stocks.

Inogen Company Profile

Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

VWR Company Profile

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC. The Americas segment consists of operations located principally in the United States and Canada, as well as in Puerto Rico, Mexico and select countries in Central and South America, including Costa Rica, Brazil, Argentina and Chile. As of December 31, 2016, the Americas segment included 67 facilities located in eight countries. As of December 31, 2016, the EMEA-APAC segment consisted of its operations located principally in Europe, as well as in certain Asia-Pacific countries, and included 110 facilities located in 26 countries. The Company’s portfolio includes chemicals, reagents, consumables, durable products and scientific equipment and instruments.

Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply